BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 21920842)

  • 1. [Diagnosis of immune-mediated neuropathies].
    Diószeghy P
    Orv Hetil; 2011 Sep; 152(39):1560-8. PubMed ID: 21920842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired inflammatory demyelinating neuropathies.
    Ensrud ER; Krivickas LS
    Phys Med Rehabil Clin N Am; 2001 May; 12(2):321-34, ix. PubMed ID: 11345010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory neuropathies.
    Whitesell J
    Semin Neurol; 2010 Sep; 30(4):356-64. PubMed ID: 20941668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune-Mediated Neuropathies.
    Gwathmey KG; Smith AG
    Neurol Clin; 2020 Aug; 38(3):711-735. PubMed ID: 32703478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immune-mediated neuropathies].
    Stoll G; Reiners K
    Nervenarzt; 2016 Aug; 87(8):887-98. PubMed ID: 27474733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guillain Barré syndrome and other immune mediated neuropathies: diagnosis and classification.
    Eldar AH; Chapman J
    Autoimmun Rev; 2014; 13(4-5):525-30. PubMed ID: 24434363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies.
    van Nes SI; Vanhoutte EK; van Doorn PA; Hermans M; Bakkers M; Kuitwaard K; Faber CG; Merkies IS
    Neurology; 2011 Jan; 76(4):337-45. PubMed ID: 21263135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatigue in immune-mediated neuropathies.
    Merkies IS; Faber CG
    Neuromuscul Disord; 2012 Dec; 22 Suppl 3():S203-7. PubMed ID: 23182640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic Immune-Mediated Polyneuropathies.
    Cox SZ; Gwathmey KG
    Clin Geriatr Med; 2021 May; 37(2):327-345. PubMed ID: 33858614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral nerve proteins as potential autoantigens in acute and chronic inflammatory demyelinating polyneuropathies.
    Lim JP; Devaux J; Yuki N
    Autoimmun Rev; 2014 Oct; 13(10):1070-8. PubMed ID: 25172243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Electrophysiological diagnosis of inflammatory neuropathies].
    Petiot P
    Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S36-44. PubMed ID: 18087228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis and therapy of vasculitic neuropathy. Consensus statement of the German Centers for Neuromuscular Disease].
    Heuss D; Schlotter-Weigel B; Sommer C;
    Fortschr Neurol Psychiatr; 2003 Apr; 71(4):172-86. PubMed ID: 12677551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune peripheral neuropathies.
    Bourque PR; Chardon JW; Massie R
    Clin Chim Acta; 2015 Sep; 449():37-42. PubMed ID: 25748038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology of immune-mediated demyelinating neuropathies--Part II: Neurology.
    Franssen H; Straver DC
    Muscle Nerve; 2014 Jan; 49(1):4-20. PubMed ID: 24037667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired immune demyelinating neuropathies.
    Dimachkie MM; Saperstein DS
    Continuum (Minneap Minn); 2014 Oct; 20(5 Peripheral Nervous System Disorders):1241-60. PubMed ID: 25299280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune-Mediated Neuropathies: Pathophysiology and Management.
    Shastri A; Al Aiyan A; Kishore U; Farrugia ME
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A common mechanism and a new categorization for anti-ganglioside antibody-mediated neuropathies.
    Uncini A
    Exp Neurol; 2012 Jun; 235(2):513-6. PubMed ID: 22507308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical spectrum of chronic acquired demyelinating polyneuropathies.
    Saperstein DS; Katz JS; Amato AA; Barohn RJ
    Muscle Nerve; 2001 Mar; 24(3):311-24. PubMed ID: 11353415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic dysimmune neuropathy. A subclassification based upon the clinical features of 102 patients.
    Busby M; Donaghy M
    J Neurol; 2003 Jun; 250(6):714-24. PubMed ID: 12796835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of immune-mediated, dysimmune neuropathies.
    Finsterer J
    Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.